# Safety of Short-course of NSAIDs in Pediatric Patients With CKD

Study · id `cardio:ct-nct06860711` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06860711](<https://clinicaltrials.gov/study/NCT06860711>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06860711

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 164 participants.

## Technical summary

Registry record NCT06860711. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-22 (actual); primary completion 2028-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 164 participants (planned count; ClinicalTrials.gov record NCT06860711, source copy `cardio:ctgov-nct06860711-2026-06-08`, retrieved 2026-10-26)
- Started: 2025-07-22 (actual) (ClinicalTrials.gov record NCT06860711, source copy `cardio:ctgov-nct06860711-2026-06-08`, retrieved 2026-10-26)
- Primary completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT06860711, source copy `cardio:ctgov-nct06860711-2026-06-08`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT06860711, source copy `cardio:ctgov-nct06860711-2026-06-08`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06860711, source copy `cardio:ctgov-nct06860711-2026-06-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06860711-2026-06-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety of Short-course of NSAIDs in Pediatric Patients With CKD
- Condition: Chronic Kidney Disease
- Condition: Pediatric Urology
- Intervention (Drug): NSAIDs
- Intervention (Drug): Placebo
- Lead sponsor: University of Colorado, Denver
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: University of Colorado, Denver (`cardio:org-university-of-colorado-denver`)

## Provenance

Content hash: 8fb39e35ef002aaa9ec571f3951fe8af6e06b46fa1dd6e9df07354d2b06daaa3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
